Statistics

	Views
Very Early Molecular Responses During The First Two Months Of Therapy Are Highly Predicitive Of Deep Molecular Responses In Newly-Diagnosed Chronic Myeloid Leukemia In Chronic Phase(CML-CP) Patients Treated Upfront With Nilotinib	4

Select a period of time:

	Views
Very Early Molecular Responses During The First Two Months Of Therapy Are Highly Predicitive Of Deep Molecular Responses In Newly-Diagnosed Chronic Myeloid Leukemia In Chronic Phase(CML-CP) Patients Treated Upfront With Nilotinib	4

	Views
United States	4

	Views
Chicago	2

RUNA digital repository